- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06473571
Effects on Dementia Caregivers
December 3, 2024 updated by: University of Central Florida
Testing a Strategy to Improve the Effects of Caregiving for Caregivers of Persons with Dementia
The Three Good Things (3GT) is a gratitude list intervention that is empirically supported (Emmons & McCullough, 2003; Seligman et al., 2005) and is a low-cost, easily accessible tool for medical and mental providers to recommend and dementia caregivers to implement independently.
Thus, this study aims to investigate the feasibility of use of 3GT in the dementia caregiving population and investigate potential therapeutic mechanisms of the intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The hypothesis predicts that Caregivers of persons diagnosed with dementia who are randomized into the intervention group (3GT) will report reduced levels of depression, burden, burnout, show an increase in levels of gratitude, increased positive emotion, and increased positive reframing (Brief COPE: Positive Reinterpretation scale and Positive Aspects of Caregiving measure) as compared to baseline levels, and post-follow up assessment in 15 days.
The participants will be recruited from local community partners and Amazon MTurk.
They will be randomized into 2 groups; one group will be asked to reflect on three good things that happened that day, and the other group will be asked to reflect on early memories.
Participants will be reminded via text message daily for 15 days and asked to document their three good things or early memories on a Qualtrics link that will be provided in the text message.
Additionally, they will be asked to answer 10 mood-related questions daily.
An ANOVA will be used to assess the pre and post intervention differences between groups for depression, burden, burnout, gratitude, positive emotion, and positive reframing.
Multilevel modeling will be used to assess the relationships between gratitude and depression at the within-subjects level and then between-subjects by intervention condition.
Identified demographic factors will be added to covary at both levels of analysis.
Data will be de-identified and stored on a University of Central Florida local hard drive, which requires special permission and password-protected profiles.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Orlando, Florida, United States, 32816
- University of Central Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Self-identified caregivers of persons with dementia at least 18 years of age
- Identify English as their primary language
- Self-report current care for an older adult with dementia identified by a medical professional
Exclusion Criteria:
- Participants that are currently receiving psychotherapy, have a diagnosis of dementia, and/or severe mental illness
- Individuals under the age of 18 years old
- Adults who cannot consent in English
- Pregnant women and prisoners will not be included in the study.
- Participants who do not have access to a phone that can not receive text messages will not be able to participate, as equipment will not be provided to Participants.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Intervention Protocol (The 3GT)
Participants will be asked to identify three things that went well that day and their role for this occurring ["What went well today, and what was your role in making it happen?"
as adapted from (Sexton & Adair, 2019)].
They will be asked to engage in this exercise for 15 days during the evening.
|
Participants will be asked to identify three things that went well that day and their role for this occurring ["What went well today, and what was your role in making it happen?"
as adapted from (Sexton & Adair, 2019)].
They will be asked to engage in this exercise for 15 days during the evening.
|
|
Active Comparator: Control Group
Participants will be asked to reflect on early memories of their life, with no specific prompts provided, for 15 days during the evening.
This activity is consistent with prior efficacy studies of 3GT (Seligman et al., 2005).
|
Participants will be asked to reflect on early memories of their life, with no specific prompts provided, for 15 days during the evening.
This activity is consistent with prior efficacy studies of 3GT (Seligman et al., 2005).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To measure gratitude using The Gratitude Questionnaire (GQ-6)
Time Frame: 6 months
|
The Gratitude Questionnaire (GQ-6), which is a widely used measure trait gratitude will be used.
The GQ-6 is a 6 item self-report questionnaire that assesses gratitude disposition in an individual.
|
6 months
|
|
To measure depressive symptoms using the Center for Epidemiologic Studies Depression Scale (CES-D 10)
Time Frame: 6 months
|
For this study, the 10-item Center for Epidemiologic Studies Depression Scale (CES-D 10) will be used to measure depressive symptoms
|
6 months
|
|
To measure burnout using The Informal Caregiver Burnout Inventory 10 (ICBI-10)
Time Frame: 6 months
|
The Informal Caregiver Burnout Inventory 10 (ICBI-10) is a new measure developed to capture burnout specifically in caregivers, aiming to validate prior attempts to modify language in general use burnout measures that typically capture occupational burnout.
|
6 months
|
|
To assess positive emotion using The Positive and Negative Affect Schedule (PANAS)
Time Frame: 6 months
|
The Positive and Negative Affect Schedule (PANAS) will be utilized to assess positive affect.
The PANAS is a 20-item self-report measure assessing two dimensions of affect (positive and negative) utilizing 5-point Likert scale.
|
6 months
|
|
To measure positive reframing using the Brief COPE Inventory: Positive Reinterpretation subscale
Time Frame: 6 months
|
To measure positive reframing, the Brief COPE Inventory: Positive Reinterpretation subscale will be used (Items 12 and 17), which is a measure that assess different types of coping utilized by individuals in stressful situations.
|
6 months
|
|
To evaluate practical implications of positive reframing using the Positive Aspects of Caregiving measure
Time Frame: 6 months
|
The Positive Aspects of Caregiving measure is a 9-item self-report scale assessing the positive factors associated with caregiving, utilizing a 5-point Likert scale ranging from 1 ("Disagree a lot") to 5 ("Agree").
|
6 months
|
|
Assess caregiver burden using the Zarit Burden Interview
Time Frame: 6 months
|
The Zarit Burden Interview, short form (ZBI-SF) will be used to measure participants subjective burden related to their caregiving role.
|
6 months
|
|
To asses ICN1-10 validity, the Burnout Measure, Short (BMS) will be used
Time Frame: 6 months
|
To provide convergent validity for the use of the ICBI-10 in this sample, the Burnout Measure, Short (BMS) will be used, which is a widely used measure of burnout.
The BMS is a 10-item, self-report measure that assess three factors of burnout including physical, emotional and mental exhaustion.
|
6 months
|
|
To measure daily depressive symptoms using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS)
Time Frame: 6 months
|
4 questions adapted from the The NIH Patient-Reported Outcomes Measurement Information System (PROMIS) short form depression item will be used.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nicole McClure, MS, MA, University of Central Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 14, 2023
Primary Completion (Actual)
January 4, 2024
Study Completion (Actual)
January 4, 2024
Study Registration Dates
First Submitted
June 19, 2024
First Submitted That Met QC Criteria
June 19, 2024
First Posted (Actual)
June 25, 2024
Study Record Updates
Last Update Posted (Estimated)
December 6, 2024
Last Update Submitted That Met QC Criteria
December 3, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00004299
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
The University of Hong KongNot yet recruiting
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on Intervention Protocol (The 3GT)
-
University of Maryland, BaltimoreWithdrawnBreast Pumping | Human Milk/BreastfeedingUnited States
-
Centre Hospitalier Intercommunal CreteilAssociation Clinique Thérapeutique Infantile du val de Marne; Groupe de Pathologies...CompletedBronchiolitis, ViralFrance
-
University of SienaRecruitingBehcet Syndrome | Uveitis | Hereditary Autoinflammatory Diseases | Castleman Disease | Schnitzler Syndrome | Scleritis | PFAPA Syndrome | Spondyloarthritis (SpA) | Still Disease | Autoinflammatory Syndrome, Unspecified | Vexas SyndromeEgypt, Spain, Turkey, Italy, China, Mexico, Saudi Arabia, Greece, Australia, Belgium, Algeria, Brazil, Iran, Islamic Republic of, Poland, India, Tunisia, Germany, Colombia, Libyan Arab Jamahiriya, Martinique, Romania, Ukraine
-
UNICANCERRecruiting
-
Professor Fernando Figueira Integral Medicine InstituteCompletedQuality of Life | Breast Cancer | Physical Activity | Physical Fitness
-
Fu Xing Hospital, Capital Medical UniversityNot yet recruitingAcquired Brain Injury | Tracheostomy DecannulationChina
-
Western University, CanadaCompletedSleep Disturbance | Borderline Personality DisorderCanada
-
University Hospital, BordeauxInstitut National de la Santé Et de la Recherche Médicale, France; Université... and other collaboratorsCompletedAlzheimer's DiseaseFrance
-
Instituto Docusse de Osteopatia e Terapia ManualCompleted
-
University of AarhusRanders Municipality, Denmark; Aarhus KommuneCompleted